BerGenBio ASA (0RU5.L)

NOK 1.72

(3.73%)

Net Debt Summary of BerGenBio ASA

BerGenBio ASA's latest annual net debt in 2023 was -155.55 Million NOK , down -3.84% from previous year.
BerGenBio ASA's latest quarterly net debt in 2024 Q2 was -200.11 Million NOK , down -70.53% from previous quarter.
BerGenBio ASA reported annual net debt of -149.79 Million NOK in 2022, up 65.51% from previous year.
BerGenBio ASA reported annual net debt of -434.26 Million NOK in 2021, up 39.57% from previous year.
BerGenBio ASA reported quarterly net debt of -117.34 Million NOK for 2024 Q1, up 24.56% from previous quarter.
BerGenBio ASA reported quarterly net debt of -225.98 Million NOK for 2023 Q2, down -212.37% from previous quarter.

Annual Net Debt Chart of BerGenBio ASA (2023 - 2014)

Historical Annual Net Debt of BerGenBio ASA (2023 - 2014)

Year	Net Debt	Net Debt Growth
2023	-155.55 Million NOK	-3.84%
2022	-149.79 Million NOK	65.51%
2021	-434.26 Million NOK	39.57%
2020	-718.6 Million NOK	-185.0%
2019	-252.14 Million NOK	29.89%
2018	-359.61 Million NOK	-2.96%
2017	-349.29 Million NOK	-143.95%
2016	-143.18 Million NOK	-98.11%
2015	-72.27 Million NOK	42.8%
2014	-126.35 Million NOK	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-200.11 Million NOK	-70.53%
2024 Q1	-117.34 Million NOK	24.56%
2023 Q2	-225.98 Million NOK	-212.37%
2023 Q1	-72.34 Million NOK	51.7%
2023 FY	-155.55 Million NOK	-3.84%
2023 Q4	-155.55 Million NOK	8.07%
2023 Q3	-169.21 Million NOK	25.12%
2022 Q1	-367.03 Million NOK	15.48%
2022 Q4	-149.79 Million NOK	33.45%
2022 FY	-149.79 Million NOK	65.51%
2022 Q3	-225.07 Million NOK	22.79%
2022 Q2	-291.49 Million NOK	20.58%
2021 Q4	-434.26 Million NOK	14.58%
2021 FY	-434.26 Million NOK	39.57%
2021 Q2	-572.79 Million NOK	12.96%
2021 Q3	-508.39 Million NOK	11.24%
2021 Q1	-658.07 Million NOK	8.42%
2020 Q2	-828.38 Million NOK	-97.52%
2020 FY	-718.6 Million NOK	-185.0%
2020 Q1	-419.39 Million NOK	-66.33%
2020 Q3	-777.85 Million NOK	6.1%
2020 Q4	-718.6 Million NOK	7.62%
2019 Q3	-289.44 Million NOK	10.7%
2019 Q2	-324.13 Million NOK	-5.78%
2019 Q1	-306.41 Million NOK	14.79%
2019 FY	-252.14 Million NOK	29.89%
2019 Q4	-252.14 Million NOK	12.89%
2018 Q1	-329.22 Million NOK	10.93%
2018 FY	-359.61 Million NOK	-2.96%
2018 Q4	-359.61 Million NOK	9.68%
2018 Q3	-398.16 Million NOK	9.77%
2018 Q2	-441.26 Million NOK	-34.03%
2017 Q4	-369.63 Million NOK	7.4%
2017 FY	-349.29 Million NOK	-143.95%
2017 Q2	-440.3 Million NOK	0.0%
2017 Q3	-399.15 Million NOK	9.35%
2016 Q4	-161.21 Million NOK	0.0%
2016 FY	-143.18 Million NOK	-98.11%
2015 FY	-72.27 Million NOK	42.8%
2014 FY	-126.35 Million NOK	0.0%

Peer Net Debt Comparison of BerGenBio ASA

Name	Net Debt	Net Debt Difference
Photocure ASA	-239.91 Million NOK	35.165%